New IUD shows promise for Long-Acting contraception
NCT ID NCT02882191
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed Phase 2 trial tested LevoCept, a levonorgestrel-releasing intrauterine system (IUD), for long-acting reversible contraception in 279 women aged 18-40. The study measured how well the IUD prevents pregnancy over 3 years, how easy it is to place, and its safety. Results will help decide if a larger Phase 3 study should go ahead.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Levonorgestrel-releasing intrauterine system (IUD)
What this could lead to
If successful, this could provide a safe and effective long-acting contraceptive option for women.
What could go wrong
This is an early-phase trial with only 279 participants, so results may not apply to everyone. Side effects or placement issues could occur.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONTRACEPTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Research Associates
Corpus Christi, Texas, 78414, United States
-
Clinical Research of Philadelphia, LLC
Philadelphia, Pennsylvania, 19114, United States
-
Columbia University Medical Center
New York, New York, 10032, United States
-
Emory University School of Medicine Gynecology/Obstetrics
Atlanta, Georgia, 30322, United States
-
Essential Access Health-Berkeley
Berkeley, California, 94710, United States
-
Essential Access Health-Los Angeles
Los Angeles, California, 90010, United States
-
Healthcare Clinical Data, Inc.
North Miami, Florida, 33161, United States
-
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, 96826, United States
-
Ohio State University
Columbus, Ohio, 43209, United States
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
-
Seattle Women's: Health, Research, Gynecology
Seattle, Washington, 98105, United States
-
University Of Colorado Department of Obstetrics & Gyncology
Aurora, Colorado, 80045, United States
-
University of California Davis Health System Department of Obstetrics and Gynecology
Sacramento, California, 95817, United States
-
University of Cincinnati Physicians Company, Inc
Cincinnati, Ohio, 45267, United States
-
University of Utah Healthcare Health Sciences Center
Salt Lake City, Utah, 84132, United States